News and Innovation

The Summer Oncology Research Fellowship (SORF) at Children’s Hospital Los Angeles and USC encourages medical students from around the nation to pursue research.

The zebrafish is one of the most powerful biomedical research tools in use today. CHLA is using them to better understand what causes pediatric cancer.

Kids from lower opportunity areas were more affected by firearm injuries during the pandemic.

A key study led by Dr. David Freyer showed that sodium thiosulfate prevented cisplatin-related hearing loss in children and led to therapy approval.

CHLA researchers found low-income children and adolescents gained more weight during the pandemic than youth from more affluent families.

Jonathan Santoro, MD, is pioneering a novel treatment—and the first clinical trial— for Down syndrome regression disorder, a devastating condition in young people with Down syndrome.

Children’s Hospital Los Angeles researchers seek better strategies to mesh ventilator rhythm with patient breathing in the pediatric intensive care unit.

The Southern California Center for Latino Health tackles health disparities in children to prevent the development of chronic diseases in adults.

International retinoblastoma research study to begin this summer to investigate liquid biopsy and its use in diagnosing and determining disease severity in retinoblastoma.

Children’s Hospital Los Angeles dedicates annual research symposium events to childhood obesity as a driver of chronic lifetime health issues including diabetes, heart disease and liver disease.